-+ 0.00%
-+ 0.00%
-+ 0.00%

BriaCell wins FDA clearance to start Bria-PROS+ prostate cancer trial

PUBT·08/05/2026 11:30:25
Listen to the news
BriaCell wins FDA clearance to start Bria-PROS+ prostate cancer trial
  • BriaCell won FDA clearance for its Bria-PROS+ IND, allowing a Phase 1/2a prostate cancer study to proceed.
  • The program previously secured a USD 2 million non-dilutive grant from the US National Cancer Institute.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Briacell Therapeutics Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608050730PRIMZONEFULLFEED9803903) on August 05, 2026, and is solely responsible for the information contained therein.